SMI
11.791,91
PKT
-135,20
PKT
-1,13
%
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 17.01.12 | Givaudan overweight | J.P. Morgan Cazenove | |
| 17.01.12 | Nestlé buy | UBS AG | |
| 17.01.12 | Holcim neutral | Sarasin Research | |
| 17.01.12 | Novartis buy | Nomura | |
| 17.01.12 | ABB (Asea Brown Boveri) outperform | Credit Suisse Group | |
| 16.01.12 | UBS neutral | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | UBS buy | Banc of America Securities-Merrill Lynch | |
| 16.01.12 | Nestlé buy | UBS AG | |
| 16.01.12 | Partners Group overweight | Morgan Stanley | |
| 16.01.12 | Nestlé hold | Vontobel Research | |
| 16.01.12 | Holcim hold | Vontobel Research | |
| 16.01.12 | Novartis buy | WestLB AG | |
| 16.01.12 | Zurich Insurance buy | Citigroup Corp. | |
| 16.01.12 | Holcim neutral | Exane-BNP Paribas SA | |
| 16.01.12 | Holcim outperform | Exane-BNP Paribas SA | |
| 13.01.12 | UBS neutral | UBS AG | |
| 13.01.12 | Holcim hold | Deutsche Bank AG | |
| 13.01.12 | Holcim buy | Deutsche Bank AG | |
| 13.01.12 | Novartis buy | Sarasin Research | |
| 13.01.12 | Geberit buy | Vontobel Research | |
| 13.01.12 | Novartis hold | Vontobel Research | |
| 12.01.12 | Givaudan sell | Citigroup Corp. | |
| 12.01.12 | Zurich Insurance neutral | Credit Suisse Group | |
| 12.01.12 | Novartis buy | Nomura | |
| 12.01.12 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
| 12.01.12 | Geberit neutral | Sarasin Research | |
| 11.01.12 | Nestlé overweight | J.P. Morgan Cazenove | |
| 11.01.12 | Sika buy | Vontobel Research | |
| 10.01.12 | Zurich Insurance buy | Société Générale Group S.A. (SG) | |
| 10.01.12 | Sika buy | Vontobel Research | |
| 09.01.12 | Holcim sell | Citigroup Corp. | |
| 09.01.12 | UBS underperform | Exane-BNP Paribas SA | |
| 09.01.12 | Zurich Insurance buy | Nomura | |
| 09.01.12 | ABB (Asea Brown Boveri) neutral | HSBC | |
| 09.01.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 09.01.12 | Novartis hold | Vontobel Research | |
| 09.01.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 06.01.12 | UBS overweight | J.P. Morgan Cazenove | |
| 06.01.12 | UBS overweight | J.P. Morgan Cazenove | |
| 06.01.12 | UBS outperform | RBC Capital Markets |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.